TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 16.1

Change

+1.43 (+9.75)%

Market Cap

N/A

Volume

0.02B

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-7.41 (-4.31%)

USD 74.41B
TAK Takeda Pharmaceutical Co Ltd A..

-0.14 (-0.93%)

USD 47.88B
HLN Haleon plc

+0.02 (+0.19%)

USD 46.89B
RDY Dr. Reddy’s Laboratories Ltd..

+0.01 (+0.08%)

USD 11.49B
ELAN Elanco Animal Health

-0.76 (-7.04%)

USD 5.51B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.14 (+1.61%)

USD 4.11B
BHC Bausch Health Companies Inc

N/A

USD 2.64B
CPHI China Pharma Holdings Inc

N/A

USD 3.69M
YCBD cbdMD Inc

-0.06 (-18.90%)

USD 1.96M
APUS Apimeds Pharmaceuticals US, In..

N/A

N/A

ETFs Containing TEVA

FLWR:SW 5.80 % 0.00 %

N/A

N/A
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

+0.30 (+0%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRPF iShares Public Limited Co.. 0.00 % 0.00 %

-0.26 (0%)

USD 2.22B
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.51 (0%)

N/A
IS3T:XETRA iShares MSCI World Size F.. 0.00 % 0.00 %

-0.92 (0%)

N/A
ISRCF iShares V Public Limited .. 0.00 % 0.00 %

+0.43 (+0%)

N/A
ISRHF iShares V Public Limited .. 0.00 % 0.00 %

+0.01 (+0%)

N/A
ISRUF iShares V Public Limited .. 0.00 % 0.00 %

-0.05 (0%)

N/A
ISRZF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF iShares Public Limited Co.. 0.00 % 0.00 %

-0.58 (0%)

N/A
ISRWF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.95% 21% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.95% 21% F 5% F
Trailing 12 Months  
Capital Gain 19.35% 79% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.35% 79% B- 85% B
Trailing 5 Years  
Capital Gain 78.69% 85% B 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 78.69% 69% C- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 13.71% 71% C- 73% C
Dividend Return 13.71% 71% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 43.06% 50% F 22% F
Risk Adjusted Return 31.84% 57% F 45% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector